Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,513 articles

Articles by Daniel Marsh

Tech-Led Gains Drive Nasdaq Futures Higher, Dow Holds Near Record
Markets

Tech-Led Gains Drive Nasdaq Futures Higher, Dow Holds Near Record

Nasdaq-100 futures advanced 1.02% in premarket trading, led by chip and AI stocks. Dow futures hovered near record levels, while oil prices fell over 1% after OPEC+ raised output targets.

INTC MU NVDA ORCL TSLA AAPL SOXQ DAL PEP
AMD Stock Rebounds Amid Nvidia Delay and Valuation Concerns
Markets

AMD Stock Rebounds Amid Nvidia Delay and Valuation Concerns

AMD shares rose 2.47% in premarket trading, recovering 56% of the prior session's loss, driven by Nvidia delay news and a customer update.

AMD NVDA INTC SOXX QQQ
AT&T Faces Dual Pressure as Dividend Date Nears Amid Starlink Concerns
Markets

AT&T Faces Dual Pressure as Dividend Date Nears Amid Starlink Concerns

AT&T shares fell 9.4% last week, wiping out roughly $18 billion in market value, as Starlink's potential mobile entry spooks investors. The dividend record date is July 10.

T TMUS VZ
Fuel Price Slide Renews Earnings Sensitivity for American Airlines
Markets

Fuel Price Slide Renews Earnings Sensitivity for American Airlines

American Airlines shares fell 1.3% in pre-market as Brent crude slid on OPEC+ output hike. Fuel cost relief renews focus on earnings sensitivity, with AAL most exposed.

AAL UAL DAL LUV
Nvidia Faces Key $200 Test After Chip Selloff, Samsung and SK Hynix in Focus
Markets

Nvidia Faces Key $200 Test After Chip Selloff, Samsung and SK Hynix in Focus

Nvidia shares near $200 as chip stocks slip before the holiday. Samsung and SK Hynix updates could influence AI supply costs.

NVDA GOOGL SNDK QQQ SPY
MP Materials' Drop Reflects Magnet Strategy Risks Over China Sales
Markets

MP Materials' Drop Reflects Magnet Strategy Risks Over China Sales

MP Materials dropped 13.4% in June after China added it to an export-control list, shifting investor focus from concentrate sales to the cost and timing of its U.S. magnet ramp.

MP USAR GM JPM GS REMX
Nasdaq Futures Lead Wall Street Higher as Chip Rotation Concerns Linger
Markets

Nasdaq Futures Lead Wall Street Higher as Chip Rotation Concerns Linger

Nasdaq futures jumped 1.06% early Monday, outpacing the Dow and S&P 500, as investors weigh a rotation out of chip stocks ahead of key earnings and Fed minutes.

PEP DAL AAPL NVDA SNDK SOXQ USO GLD
India VIX Hovers Near Four-Month Low Amid Calm Nifty Rally
Markets

India VIX Hovers Near Four-Month Low Amid Calm Nifty Rally

India VIX trades near a four-month low, signaling reduced market fear as the Nifty rally continues. The low volatility environment supports the rally, with banks leading gains.

Q2 Inflows Surge as Rally Fuels Demand for U.S. Stock Funds
Markets

Q2 Inflows Surge as Rally Fuels Demand for U.S. Stock Funds

U.S. stock funds attracted significant net inflows in Q2, driven by the market rally. SpaceX is set to join the Nasdaq-100, while Capcom and Wheaton Precious Metals highlight growth and valuation opportunities.

QQQ WPM SPY
BofA Flags S&P 500's 7,100 Level as Key Test for AI Rally
Markets

BofA Flags S&P 500's 7,100 Level as Key Test for AI Rally

Bank of America warns the S&P 500's AI-driven rally could face its first major test near the 7,100 level, with technical signals and extreme speculation suggesting a correction may be imminent.

BAC NVDA SNDK MSFT GOOGL AMZN SOXQ
Recursion Pharma Rallies Past Biotech ETFs; Insider Sales and Cash Position in Focus
Markets

Recursion Pharma Rallies Past Biotech ETFs; Insider Sales and Cash Position in Focus

Recursion Pharmaceuticals (RXRX) surged 8% in a four-session week, beating biotech ETFs. Filings show insider sales, while the company's $665M cash position and upcoming data updates remain key.

RXRX XBI IBB SPY GS
Snap Shares Rally 9.8% in Holiday-Shortened Week; Ad Revenue in Focus
Analysis

Snap Shares Rally 9.8% in Holiday-Shortened Week; Ad Revenue in Focus

Snap shares surged 9.8% in a holiday-shortened week, outperforming Meta and Pinterest. Focus remains on ad revenue as North America daily active users decline.

SNAP META PINS